product&#32

6 trials

Sponsors

Yaneng Biotechnology (Shenzhen) Co., Ltd., West China Hospital, Sichuan University, Shenzhen Second People's Hospital, Affiliated Hospital of Zunyi Medical University, Beijing You'an Hospital, Capital Medical University

Conditions

Brain InjuryHuman Immunodeficiency VirusNSCLCNovel Coronavirus Pneumonia (COVID-19)cervical lesion

Early Phase 1

Clinical study of a novel high sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19) based on CRISPR-cas protein

RecruitingChiCTR2000029810

Shenzhen Second People's HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-16Updated: 2020-02-17

Cancelled by the investigator Application of cas13a-mediated RNA detection in the assay of novel coronavirus nucleic acid (COVID-19)

RecruitingChiCTR2000030706

Affiliated Hospital of Zunyi Medical UniversityNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-09Updated: 2020-03-16

Clinical trial of human immunodeficiency virus antigen and antibody detection kit (chemiluminescence method)

Active, not recruitingChiCTR2000033312

Beijing You'an Hospital, Capital Medical UniversityHuman Immunodeficiency Virus

Start: 2020-06-15Updated: 2020-06-01

A clinical study of serological examination in diagnosis and prognosis evaluation of central nervous system diseases

RecruitingChiCTR2100043218

Xiang'an Hospital of Xiamen UniversityBrain Injury

Start: 2021-02-16Updated: 2021-05-24

Unknown Phase

A clinical trial for Human papillomavirus genotyping (15 types) detection kit (PCR-reverse dot hybridization)

Active, not recruitingChiCTR1800019779

Yaneng Biotechnology (Shenzhen) Co., Ltd.cervical lesion

Start: 2018-12-01Updated: 2018-12-04

Multi-gene mutation detection kit for human lung cancer (Hybridization capture sequencing) clinical trial

RecruitingChiCTR1800019838

West China Hospital, Sichuan UniversityNSCLC

Start: 2018-12-01Updated: 2018-12-04